Franziska Zabel
Ramismuhle, ZH 8487, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy.
Journal: NPJ vaccines
Published: May 10, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines.
Journal: Frontiers in immunology
Published: October 25, 2016
Transcutaneous applications for vaccination and immunotherapy
Journal: Praxis
Published: October 12, 2014
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Journal: European journal of immunology
Published: July 09, 2014
Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivo.
Journal: Nature communications
Published: May 19, 2014
Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 14, 2014
Vaccination against Alzheimer disease: an update on future strategies.
Journal: Human vaccines & immunotherapeutics
Published: February 19, 2014
Bacterially produced recombinant influenza vaccines based on virus-like particles.
Journal: PloS one
Published: April 16, 2013
Virus-induced humoral immunity: on how B cell responses are initiated.
Journal: Current opinion in virology
Published: February 13, 2013
The antihistamines clemastine and desloratadine inhibit STAT3 and c-Myc activities and induce apoptosis in cutaneous T-cell lymphoma cell lines.
Journal: Experimental dermatology
Published: January 09, 2013
Last Updated: 09/26/2026